US authorises Pfizer Covid-19 pill, first for at-home use
The long-awaited milestone comes as US cases, hospitalisations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that could overwhelm hospitals.
PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates and issue of duplicate share certificates
New Zealand links 26-year-old man's death to Pfizer COVID-19 vaccine
The death is New Zealand's second linked to a known but rare side effect from the vaccine after health authorities in August reported a woman had died after taking her doses.
Covid: Pfizer vax for 2 to 4 year-olds fails to produce expected immunity
The Covid vaccine developed for small children aged 2 to 4-year-olds by US drug maker Pfizer generates weaker immune response than expected, the company has announced
Sinopharm, J&J, Sputnik vaccines are weaker against Omicron, says report
The study also found that the lowest reduction in protective antibodies come from a combination of prior infection and two doses of Pfizer Inc.'s mRNA shots
Pfizer's Covid-19 antiviral pill marks significant step forward: Biden
US President Joe Biden on Tuesday (local time) said that Pfizer's COVID-19 antiviral pill mark a significant step forward in the path out of the pandemic. PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received requests for issue of duplicate Share Certificate(s) from the Shareholder(s).
Netherlands approves vaccination of children aged 5-11 against Covid-19
The Netherlands approved the recommendation of the Health Council to vaccinate children aged 5-11 against COVID-19, the cabinet said in a statement."Children aged 5-11 can now be vaccinated against coronavirus," it said.The vaccination of healthy children aged 5-11 will begin in the second half of January 2022. Children of this age group with chronic diseases will be vaccinated from December 20. All of them will be offered the Pfizer/BioNTech vaccine.
World rushes to boost against Omicron, but questions remain
In the days after earliest findings showed that omicron caused a 25 to 40-fold loss of neutralizing antibodies from the Pfizer Inc.-BioNTech SE vaccine, the second-most used shot across the world, the U.S. expanded booster access to teenagers while countries like the U.K. and South Korea are slashing wait times for a third dose in half, to three months. Germany's vaccination panel recommends doses for children aged 5-11
Germany's independent vaccination advisory panel on Thursday said it was recommending COVID-19 shots for children aged 5 to 11 with pre-existing conditions or who are in close contact to vulnerable people. The expert panel also said that young kids without pre-existing conditions can be vaccinated if there is an individual desire to do so a step short of advising that all children in that age group get the shots. The panel, known by its German acronym STIKO, said in a statement that children aged 5-11 should receive two doses of the Pfizer-BioNTech vaccine, three to six weeks apart. The recommendation, which isn't binding and may still be amended after consultation with health officials, means doctors in Germany will likely begin offering vaccinations to younger children next week, when the appropriate shots become available. About 69.3% of the country's total population is fully vaccinated.